Why could passive Immunoglobulin E antibody therapy be safe in clinical oncology?
about
Why could passive Immunoglobulin E antibody therapy be safe in clinical oncology?
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Why could passive Immunoglobulin E antibody therapy be safe in clinical oncology?
@en
Why could passive Immunoglobulin E antibody therapy be safe in clinical oncology?
@nl
type
label
Why could passive Immunoglobulin E antibody therapy be safe in clinical oncology?
@en
Why could passive Immunoglobulin E antibody therapy be safe in clinical oncology?
@nl
prefLabel
Why could passive Immunoglobulin E antibody therapy be safe in clinical oncology?
@en
Why could passive Immunoglobulin E antibody therapy be safe in clinical oncology?
@nl
P2860
P1476
Why could passive Immunoglobulin E antibody therapy be safe in clinical oncology?
@en
P2093
P2860
P304
P356
10.1111/J.1365-2222.2011.03764.X
P577
2011-05-05T00:00:00Z